GT
IOVA icon

Glenmede Trust’s Iovance Biotherapeutics IOVA Stock Holding History

Glenmede Trust’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,233
Closed -$374K – 1386
2024
Q1 		$374K Buy
+25,233
New +$294K ﹤0.01% 1004
2021
Q1 		– Sell
-15,009
Closed -$696K – 1225
2020
Q4 		$696K Buy
15,009
+5,571
+59% +$221K ﹤0.01% 759
2020
Q3 		$310K Buy
9,438
+2,008
+27% +$61.6K ﹤0.01% 908
2020
Q2 		$203K Buy
7,430
+400
+6% +$13.2K ﹤0.01% 1007
2020
Q1 		$194K Hold
7,030
– – ﹤0.01% 1203
2019
Q4 		$194K Buy
7,030
+325
+5% +$7.39K ﹤0.01% 1203
2019
Q3 		$122 Buy
6,705
+135
+2% +$2.98K ﹤0.01% 1336
2019
Q2 		$161 Buy
+6,570
New +$99K ﹤0.01% 1239

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return